<?xml version="1.0" encoding="ISO-8859-1"?>
<rss version="2.0">
    <channel>
        <title>PR.com Press Releases: CureHIV News</title>
        <description>Latest news releases from PR.com for CureHIV.</description>
        <link>http://www.pr.com/press-releases</link>
        <lastBuildDate>Thu, 04 Dec 2008 11:10:07 -0500</lastBuildDate>
        <image>
            <url>http://www.pr.com/images/logo_white.jpg</url>
            <title>Press Releases from PR.com</title>
            <link>http://www.pr.com/</link>
            <width>68</width>
            <height>69</height>
            <description>PR.com provides Free Press Release Distribution, &amp; is a unique Directory of Businesses, Products, Services, &amp; Jobs - in all industries.  Find Full Company Profiles.</description>
        </image>
        <copyright>© 2008 PR Worldwide, Inc.</copyright>
        <ttl>60</ttl>
        <item>
            <title>CureHIV Seeks Funding for LiSAVIOR from Bill and Melinda Gates' Grand Challenges to Cure HIV</title>
            <link>http://www.pr.com/press-release/79183</link>
            <description>Dr. Roger Kenneth Hershline PhD MD, Global Humanceuticals, Inc and CureHIV apply to Bill and Melinda Gates' Grand Challenges in Global Health to fund the new HIV non-traditional drug LiSAVIOR. Current drug and vaccination treatments do not treat the growth of HIV in the gastrointestinal tract. [PR.com - April 02, 2008]</description>
            <author>CureHIV</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/79183</guid>
        </item>
        <item>
            <title>Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc.  Donates New Powerful Class of HIV Viral  Drug</title>
            <link>http://www.pr.com/press-release/51573</link>
            <description>Dr. Roger Kenneth Hershline PhD  MD, Chairman and Founder of CureHIV.us, agreed to provide samples of Global Humanceuticals, Inc’s NIAID#11039, a new powerful class of anti-HIV drug to clinical researchers. The drug is able de-activates the virus even if diluted nearly a billion times. [PR.com - September 09, 2007]</description>
            <author>CureHIV</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/51573</guid>
        </item>
        <item>
            <title>CureHIV Predicts Number of HIV Cases to Skyrocket</title>
            <link>http://www.pr.com/press-release/45264</link>
            <description>Dr. Hershline states that, baring a new preventative, CureHIV now predicts over 700 million worldwide HIV infected humans by the New Year 2018, as this global pandemic emerges. [PR.com - July 15, 2007]</description>
            <author>CureHIV</author>
            <guid isPermaLink="true">http://www.pr.com/press-release/45264</guid>
        </item>
    </channel>
</rss>
